FDA Inspection 1229273 — MNJ Institute Of Medical Oncology And Regional Cancer Center
The FDA completed an inspection of MNJ Institute Of Medical Oncology And Regional Cancer Center on Jan 12, 2024 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Clinical BA/BE